208 related articles for article (PubMed ID: 11365545)
1. Four new antiretroviral medications will soon offer more options to HIV patients.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(4):1-3. PubMed ID: 11365545
[TBL] [Abstract][Full Text] [Related]
2. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches for the treatment of HIV.
Arroyo HT
Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450
[TBL] [Abstract][Full Text] [Related]
4. The new drugs and how to use them.
Gallant JE
Hopkins HIV Rep; 1999 Jan; 11(1):2, 7. PubMed ID: 11366160
[TBL] [Abstract][Full Text] [Related]
5. Drugs of tomorrow.
Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
[TBL] [Abstract][Full Text] [Related]
6. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
Lalezari JP; DeJesus E; Northfelt DW; Richmond G; Wolfe P; Haubrich R; Henry D; Powderly W; Becker S; Thompson M; Valentine F; Wright D; Carlson M; Riddler S; Haas FF; DeMasi R; Sista PR; Salgo M; Delehanty J
Antivir Ther; 2003 Aug; 8(4):279-87. PubMed ID: 14518696
[TBL] [Abstract][Full Text] [Related]
7. I want a new drug. An overview of three new anti-HIV drugs.
Simmons P
Res Initiat Treat Action; 1998 Jun; 4(3):9-11. PubMed ID: 11365539
[TBL] [Abstract][Full Text] [Related]
8. New expanded access drugs for use in combination therapy.
Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
[TBL] [Abstract][Full Text] [Related]
9. Options when HIV treatments fail.
Treat Rev; 1998; (No 28):7-9. PubMed ID: 11365426
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
[TBL] [Abstract][Full Text] [Related]
12. The medical merry-go-round: drugs for 1998 are new but not novel.
Gilden D
GMHC Treat Issues; 1997-1998 Winter; 12(1):18-25. PubMed ID: 11364984
[TBL] [Abstract][Full Text] [Related]
13. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
Hammer SM; Vaida F; Bennett KK; Holohan MK; Sheiner L; Eron JJ; Wheat LJ; Mitsuyasu RT; Gulick RM; Valentine FT; Aberg JA; Rogers MD; Karol CN; Saah AJ; Lewis RH; Bessen LJ; Brosgart C; DeGruttola V; Mellors JW;
JAMA; 2002 Jul; 288(2):169-80. PubMed ID: 12095381
[TBL] [Abstract][Full Text] [Related]
14. What's new, what's next?
Elwell A
Posit Dir News; 1999; 11(1):1, 3-13. PubMed ID: 11366098
[TBL] [Abstract][Full Text] [Related]
15. New drugs in development.
Proj Inf Perspect; 1998 Sep; (25):8. PubMed ID: 11365851
[TBL] [Abstract][Full Text] [Related]
16. Clinical update: new drugs for HIV/AIDS.
Gracia Jones S; Baggett TH
Medsurg Nurs; 1999 Apr; 8(2):108-12. PubMed ID: 10410008
[TBL] [Abstract][Full Text] [Related]
17. New drugs on the horizon.
Proj Inf Perspect; 1998 Apr; (24):10-3. PubMed ID: 11365712
[TBL] [Abstract][Full Text] [Related]
18. New drugs: amprenavir and abacavir.
TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
[Next] [New Search]